These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 17035421)

  • 1. Optimal therapy for methicillin-resistant Staphylococcus aureus pneumonia: what is the best dosing regimen?
    Rello J; Mallol J
    Chest; 2006 Oct; 130(4):938-40. PubMed ID: 17035421
    [No Abstract]   [Full Text] [Related]  

  • 2. What does it mean: appropriate therapy for methicillin-resistant Staphylococcus aureus?
    Viale P; Pea F
    Crit Care Med; 2007 Mar; 35(3):991; author reply 991-2. PubMed ID: 17421115
    [No Abstract]   [Full Text] [Related]  

  • 3. Predictors of mortality for methicillin-resistant Staphylococcus aureus health-care-associated pneumonia: specific evaluation of vancomycin pharmacokinetic indices.
    Jeffres MN; Isakow W; Doherty JA; McKinnon PS; Ritchie DJ; Micek ST; Kollef MH
    Chest; 2006 Oct; 130(4):947-55. PubMed ID: 17035423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vancomycin dosing for methicillin-resistant staphylococcus aureus nosocomial pneumonia.
    Hall RG; Adams-Huet B
    Chest; 2007 Sep; 132(3):1100-1; author reply 1102-3. PubMed ID: 17873214
    [No Abstract]   [Full Text] [Related]  

  • 5. Methicillin-resistant Staphylococcus aureus pneumonia treatment: do not confuse pharmacokinetics and pharmacodynamics.
    Moine P; Bédos JP
    Chest; 2007 Sep; 132(3):1101, author reply 1102-3. PubMed ID: 17873216
    [No Abstract]   [Full Text] [Related]  

  • 6. MRSA pneumonia: better outcome through continuous infusion of vancomycin?
    Blot S
    Crit Care Med; 2005 Sep; 33(9):2127-8. PubMed ID: 16148496
    [No Abstract]   [Full Text] [Related]  

  • 7. Cost-effectiveness analysis of linezolid compared with vancomycin for the treatment of nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus.
    Estes L; Orenstein R
    Clin Ther; 2007 Feb; 29(2):381-3; author reply 383-4. PubMed ID: 17472831
    [No Abstract]   [Full Text] [Related]  

  • 8. Appropriate pharmacokinetic index for outcome in Staphylococcus aureus pneumonia.
    Potoski BA; Paterson DL
    Chest; 2007 Sep; 132(3):1101-2; author reply 1102-3. PubMed ID: 17873215
    [No Abstract]   [Full Text] [Related]  

  • 9. A retrospective analysis of possible renal toxicity associated with vancomycin in patients with health care-associated methicillin-resistant Staphylococcus aureus pneumonia.
    Jeffres MN; Isakow W; Doherty JA; Micek ST; Kollef MH
    Clin Ther; 2007 Jun; 29(6):1107-15. PubMed ID: 17692725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness analysis of linezolid compared with vancomycin for the treatment of nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus.
    Estes L; Orenstem R
    Clin Ther; 2007 Apr; 29(4):759-60; author reply 760-1. PubMed ID: 17617300
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacologic treatment options for nosocomial pneumonia involving methicillin-resistant Staphylococcus aureus.
    Maclayton DO; Hall RG
    Ann Pharmacother; 2007 Feb; 41(2):235-44. PubMed ID: 17299012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of bactericidal activities of intermittent and continuous infusion dosing of vancomycin against methicillin-resistant Staphylococcus aureus and Enterococcus faecalis.
    Klepser ME; Patel KB; Nicolau DP; Quintiliani R; Nightingale CH
    Pharmacotherapy; 1998; 18(5):1069-74. PubMed ID: 9758317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential impact of vancomycin pulmonary distribution on treatment outcomes in patients with methicillin-resistant Staphylococcus aureus pneumonia.
    Scheetz MH; Wunderink RG; Postelnick MJ; Noskin GA
    Pharmacotherapy; 2006 Apr; 26(4):539-50. PubMed ID: 16553514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vancomycin, unbeatable for methicillin-resistant Staphylococcus aureus hospital-acquired pneumonia? Really?
    Luna CM; Bruno D; Aruj P
    Crit Care Med; 2010 Sep; 38(9):1910-2. PubMed ID: 20724890
    [No Abstract]   [Full Text] [Related]  

  • 15. Outcomes associated with AUC24/MIC nomogram dosing of vancomycin.
    Michalets EL; Pounders CL; Hollis SJ; Sutherland S
    Ann Pharmacother; 2011 May; 45(5):687-9. PubMed ID: 21521857
    [No Abstract]   [Full Text] [Related]  

  • 16. Impact of weight on treatment efficacy and safety in complicated skin and skin structure infections and nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus.
    Puzniak LA; Morrow LE; Huang DB; Barreto JN
    Clin Ther; 2013 Oct; 35(10):1557-70. PubMed ID: 24011955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monitoring of vancomycin serum levels for the treatment of staphylococcal infections.
    Kitzis MD; Goldstein FW
    Clin Microbiol Infect; 2006 Jan; 12(1):92-5. PubMed ID: 16460555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibiotic management of ventilator-associated pneumonia due to antibiotic-resistant gram-positive bacterial infection.
    Kollef MH
    Eur J Clin Microbiol Infect Dis; 2005 Dec; 24(12):794-803. PubMed ID: 16341681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of methicillin-resistant Staphylococcus aureus pneumonia.
    Luna CM; Boyeras Navarro ID
    Curr Opin Infect Dis; 2010 Apr; 23(2):178-84. PubMed ID: 20075728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ventilator-associated pneumonia by Staphylococcus aureus. Comparison of methicillin-resistant and methicillin-sensitive episodes.
    Rello J; Torres A; Ricart M; Valles J; Gonzalez J; Artigas A; Rodriguez-Roisin R
    Am J Respir Crit Care Med; 1994 Dec; 150(6 Pt 1):1545-9. PubMed ID: 7952612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.